The Trump administration is pursuing regulatory changes that experts warn could severely restrict federal research funding and impede scientific progress. More than a year and a half after attempting to eliminate approximately 13,350 federal research grants—a move largely halted by court rulings—the administration is now seeking to curtail grant spending through revisions proposed by the Office of Management and Budget (OMB).

Established in 1970 as a neutral agency responsible for managing the executive branch’s budget proposals, the OMB is currently led by Russell Vought, a close ally of former President Trump and a key figure in the administration's Project 2025 initiative. The proposed rules, detailed in a complex set of documents spanning over 400 pages, would affirm the government’s authority to terminate grants at any time and reject funding for studies that do not align with the executive branch’s ideological preferences.

Critics say the regulations also threaten researchers’ ability to cover open-access publication fees, attend scientific conferences, and collaborate internationally—elements deemed essential for innovation, public engagement, and scientific debate. Nancy Krieger, a professor at the Harvard T.H. Chan School of Public Health, recounted that her own federally funded research on the health impacts of discrimination was terminated in early 2025 due to its subject matter. She warns that the new rules represent a "quiet" attempt to reassert control over federally funded work by allowing political appointees to determine which projects receive support and subsequently micromanage them.

The OMB’s announcement of the proposed regulations in May initiated a public comment period lasting only 45 days—significantly shorter than the usual 60 to 90 days—despite the complexity and length of the documents. Observers note the administration’s efforts to consolidate power within the OMB, shifting its stated mission from faithfully executing congressional mandates to emphasizing loyalty to the president’s agenda.

While the administration asserts these changes will enhance accountability, opponents contend that the rules effectively amount to a censorship mechanism. They argue that prioritizing politics over evidence undermines the transparency and rigor that underpin scientific inquiry and public policy. A 2023 Congressional report acknowledged that while the OMB must fulfill its statutory responsibilities, it may also pursue the president’s policy priorities—an interpretation that critics suggest is being stretched to justify politicizing grant decisions.

The regulations extend beyond scientific research, affecting all federal grants, including those for Medicaid, transportation, education, food assistance, and libraries. Elizabeth Ginexi, a former federal employee, has highlighted concerns that subjecting such funding to political discretion jeopardizes vital government services.

Should the rule go into effect as planned on October 1, experts warn it could have wide-ranging negative consequences for American science, education, and essential community resources. Observers urge affected stakeholders to participate in the public comment process opposing the rule and to inform congressional representatives of their concerns.